These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 15914526

  • 1. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [Abstract] [Full Text] [Related]

  • 2. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS, AIDS Clinical Trials Group 329 Study Team, National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group.
    Arch Intern Med; 2005 Mar 14; 165(5):578-85. PubMed ID: 15767536
    [Abstract] [Full Text] [Related]

  • 3. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T.
    J Am Soc Nephrol; 2006 Aug 14; 17(8):2307-14. PubMed ID: 16825332
    [Abstract] [Full Text] [Related]

  • 4. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R.
    Int J Obes Relat Metab Disord; 1995 Sep 14; 19(9):614-24. PubMed ID: 8574271
    [Abstract] [Full Text] [Related]

  • 5. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M, ACTG 313 Study Team.
    J Clin Endocrinol Metab; 2007 Feb 14; 92(2):563-70. PubMed ID: 17090640
    [Abstract] [Full Text] [Related]

  • 6. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA, E-1696 Study Investigators.
    HIV Med; 2006 Apr 14; 7(3):146-55. PubMed ID: 16494628
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
    Sardar P, Jha A, Roy D, Majumdar U, Guha P, Roy S, Banerjee R, Banerjee AK, Bandyopadhyay D.
    HIV Clin Trials; 2010 Apr 14; 11(4):220-9. PubMed ID: 20974577
    [Abstract] [Full Text] [Related]

  • 8. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):137-46. PubMed ID: 10048900
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.
    JAMA; 2002 Nov 13; 288(18):2282-92. PubMed ID: 12425705
    [Abstract] [Full Text] [Related]

  • 10. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR, Stocks K, Faulkner S, Wiehler H, Lorenz C, Jentzen W, Hengge D, Ringham G.
    HIV Clin Trials; 2003 Nov 13; 4(3):150-63. PubMed ID: 12815555
    [Abstract] [Full Text] [Related]

  • 11. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.
    JAMA; 1999 Apr 14; 281(14):1282-90. PubMed ID: 10208143
    [Abstract] [Full Text] [Related]

  • 12. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM, AIDS Clinical Trials Group Protocol A5079 Study Team.
    J Clin Endocrinol Metab; 2007 Mar 14; 92(3):1049-57. PubMed ID: 17164307
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.
    Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.
    Ann Intern Med; 1996 Dec 01; 125(11):865-72. PubMed ID: 8967666
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting--a clinical research center study.
    Mulligan K, Tai VW, Schambelan M.
    J Clin Endocrinol Metab; 1998 May 01; 83(5):1542-7. PubMed ID: 9589652
    [Abstract] [Full Text] [Related]

  • 15. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
    Van Loan MD, Strawford A, Jacob M, Hellerstein M.
    AIDS; 1999 Feb 04; 13(2):241-8. PubMed ID: 10202830
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
    Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.
    Ann Intern Med; 1996 Dec 01; 125(11):873-82. PubMed ID: 8967667
    [Abstract] [Full Text] [Related]

  • 17. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
    Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ.
    J Clin Endocrinol Metab; 2003 Jul 01; 88(7):3167-76. PubMed ID: 12843161
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
    Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.
    AIDS; 2003 Mar 28; 17(5):699-710. PubMed ID: 12646793
    [Abstract] [Full Text] [Related]

  • 19. Use of growth hormone and other anabolic agents in AIDS wasting.
    Mulligan K, Tai VW, Schambelan M.
    JPEN J Parenter Enteral Nutr; 1999 Mar 28; 23(6 Suppl):S202-9. PubMed ID: 10571456
    [Abstract] [Full Text] [Related]

  • 20. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
    Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen S.
    J Clin Endocrinol Metab; 1999 Apr 28; 84(4):1268-76. PubMed ID: 10199766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.